The U.S. computer-aided detection (CAD) market is estimated to be valued at US$ 632.0 million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030).
Analysts’ Views on U.S. Computer-Aided Detection (CAD) Market:
The availability of single-packed software solutions for multiple applications is expected to offer lucrative growth opportunities for players in the market. Most software is specially designed to analyze images from one modality for specific indications. CAD software that can be used to analyze images from more than one modality is available in the market. However, demand could increase if a single software was developed with the capability of analyzing images from different modalities for many indications without complications.
Figure 1. U.S. Computer-Aided Detection (CAD) Market Share (%), by Infection Type, 2023
To learn more about this report, Request sample copy
U.S. Computer-Aided Detection (CAD) Market – Driver
Increasing demand for computer-aided detection (CAD) solutions
Increasing demand for computer-aided detection (CAD) solutions is expected to drive the U.S. computer-aided detection (CAD) market over the forecast period. Computer-aided detection (CAD) units are increasing in multispecialty hospitals. Versatile diagnostics systems are preferred in multispecialty hospitals, owing to benefits such as cost-effectiveness and greater return on investment.
U.S. Computer-Aided Detection (CAD) Market – Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.
Figure 2. U.S. Computer-Aided Detection (CAD) Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2030
To learn more about this report, Request sample copy
U.S. Computer-Aided Detection (CAD) Market Segmentation:
The U.S. computer-aided detection (CAD) market report is segmented into product type, and imaging modality.
Based on Product Type, the market is segmented into breast CAD, abdominal CAD, prostrate CAD, cardiovascular CAD, and others. Out of which, the breast CAD segment is expected to dominate the infection surveillance solutions market during the forecast period and this is due to the increase in prevalence of breast cancer.
Based on Imaging Modality, the market is segmented into mammography, X-ray imaging, MRI, computed tomography, ultrasound, and others. Out of which the MRI segment is expected to hold a dominant position in the market over the forecast period due to the increase in the number of hospitals.
U.S. Computer-Aided Detection (CAD) Market Cross Sectional Analysis:
In product type segment, breast CAD holds a dominant segment in North America region due to the increasing prevalence of breast cancer. For instance, in March 2023, an article was published by National Cancer Institute, stated that the most common type of cancer is breast cancer, with 300,590 new cases expected in the U.S. in 2023.
U.S. Computer-Aided Detection (CAD) Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 683.8 Mn |
Historical Data for: | 2017 to 2021 | Forecast Period: | 2023 to 2030 |
Forecast Period 2023 to 2030 CAGR: | 14.2% | 2030 Value Projection: | US$ 1,732.3 Mn |
Segments covered: |
|
||
Companies covered: |
iCAD, Inc., Koninklijke Philips N.V., Holojic, Inc., Carestream Health, Inc., Siemens AG, GE Healthcare, EDDA Technology, Inc., EDDA Technology, Inc., and other prominent players. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
U.S. Computer-Aided Detection (CAD) Market: Key Developments
Increase in approval by the regulatory authorities is expected to drive the U.S. computer-aided detection (CAD) market over the forecast period. For instance, in August 2022, Bot Image, an Omaha-based MRI medical device company, developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
U.S. Computer-Aided Detection (CAD) Market: Key Trends
Increase in product launches by the key players
Increasing product launches by the key market players is expected to drive the market over the forecast period. For instance, in March 2020, Delft Imaging, diagnostic imaging solutions manufacturer, partnered with Thirona, Radboudumc, Bernhoven,(Netherlands), HT medica (Spain), and Fakultas Kedokteran UI (Indonesia) to develop CAD4COVID (Computer-Aided Detection for COVID-19) to help triage patients and inform the care pathway.
U.S. Computer-Aided Detection (CAD) Market: Restraint
Lack of trained radiologists and technicians
The U.S. computer-aided detection (CAD) market can be hindered by a lack of trained radiologists and technicians, radiologists and technicians are required to have the prerequisite technical skills to operate computer-aided detection (CAD) systems. The lack of trained radiologists and technicians is a factor restraining the growth of the market. To overcome this, hospitals and centers need to hire fully trained radiologists and technicians.
U.S. Computer-Aided Detection (CAD) Market - Key Players
Major players operating in the U.S. computer-aided detection (CAD) market include iCAD, Inc., Koninklijke Philips N.V., Holojic, Inc., Carestream Health, Inc., Siemens AG, GE Healthcare, EDDA Technology, Inc., EDDA Technology, Inc., and other prominent players.
*Definition: Computer-aided detection (CAD) software constitutes a set of algorithms, which uses pattern recognition methods predominantly to aid radiologists in detecting potential disease lesions or regions in the human body.
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients